Edit this postWhat Are Brokerages Saying About ICICI Lombard After Its Q2 Results?
ICICI Lombard’s Q2 performance has triggered a mix of upgrades and cautious stances from leading brokerages. While profitability improved YoY, the company’s growth in Gross Direct Premium Income (GDPI) and market share dynamics have divided analyst sentiment. Elara upgraded the stock to “Buy” from “Accumulate,” whereas Goldman Sachs maintained a “Neutral” call, and Nuvama continued its positive stance with a target price of ₹2,340.
According to Goldman Sachs, the insurer’s profitability improvement, with a combined ratio of 105.1%, shows operational strength despite a 2% YoY GDPI decline. However, they see limited upside given the current valuation of ~30x FY27E P/E, which aligns with the five-year average. They have maintained a Neutral rating with a revised target of ₹1,975.
For intraday and positional strategies tracking market-linked insurance plays, explore Nifty Tip and BankNifty Tip for expert analysis and live insights.
Elara Securities, meanwhile, upgraded the stock to “Buy” from “Accumulate,” citing stronger-than-expected PAT growth of 18% YoY and robust solvency at 2.73x. The brokerage expects ROE to stay above 21% as investment yields improve. The firm raised its target price to ₹2,250, factoring in better retail health performance and GST-related tailwinds aiding affordability in motor and health segments.
Nuvama maintained a “Buy” rating with a target price of ₹2,340, noting steady premium growth and an 18% YoY rise in adjusted PAT. Despite minor underwriting losses, they remain optimistic about H2FY26 recovery, supported by motor demand revival and group health momentum. The firm also cited improving investment income yields near 9% as a key positive driver.
The consensus across brokerages is that ICICI Lombard’s underwriting environment remains challenging due to elevated competition and claim inflation. However, rising profitability, strong solvency ratios, and upcoming GST-led boosts could sustain long-term growth. Most analysts now expect steady mid-teen PAT CAGR through FY25–28E, supported by better pricing discipline.
For more market-aligned research on financial stocks and benchmark index moves, visit Nifty Options Tip for daily strategic updates.
Going forward, analysts expect moderate growth as the insurer adapts to regulatory shifts and sectoral competition. The Street remains divided between high valuation caution and long-term growth optimism, with the consensus price target band hovering between ₹1,975 and ₹2,340.
Investor Takeaway: Indian-Share-Tips.com Nifty Expert Gulshan Khera, CFP®, who is also a SEBI Regd Investment Adviser, observes that the latest ICICI Lombard reviews reflect a maturing general insurance market in India. He notes that prudent investors should view short-term volatility as an opportunity for staggered accumulation, given the company’s strong franchise and capital discipline.
Related Queries
Why Did Elara Upgrade ICICI Lombard to Buy Post Q2FY26?
What Are the Key Risks to ICICI Lombard’s Growth Outlook?
How Do Brokerages Differ in Their Valuation of ICICI Lombard?
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment adviser before making any investment decisions. The views expressed are general in nature and may not suit individual investment objectives or financial situations.
